| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 0.89▲ | 0.88▲ | 0.88▲ | 0.86▲ | 0.98▼ |
| MA10 | 0.87▲ | 0.87▲ | 0.87▲ | 0.87▲ | 1.18▼ |
| MA20 | 0.86▲ | 0.86▲ | 0.86▲ | 0.98▼ | 1.85▼ |
| MA50 | 0.90▲ | 0.93▲ | 0.95▼ | 1.23▼ | 2.80▼ |
| MA100 | 1.00▼ | 1.07▼ | 1.10▼ | 1.91▼ | 22.06▼ |
| MA200 | 1.14▼ | 1.22▼ | 1.26▼ | 2.24▼ | 3,176.96▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.011▲ | 0.013▲ | 0.014▲ | 0.014▲ | 0.186▲ |
| RSI | 67.236▲ | 59.959▲ | 58.056▲ | 36.287▼ | 31.601▼ |
| STOCH | 71.619 | 68.963 | 70.417 | 19.464▼ | 5.606▼ |
| WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -60.917 | -95.183▼ |
| CCI | 237.422▲ | 282.758▲ | 285.596▲ | -8.410 | -91.141 |
|
Saturday, November 22, 2025 09:05 AM
SAN DIEGO, CA / ACCESS Newswire / November 20, 2025 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on rebalancing ...
|
|
Thursday, November 06, 2025 01:59 PM
Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is focused on rebalancing inflammation to optimize health, today reported its ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 26/11/25 | 0.8701 | 0.9298 | 0.8701 | 0.9298 | 93,982 |
| 25/11/25 | 0.8501 | 0.8629 | 0.8391 | 0.8391 | 42,059 |
| 24/11/25 | 0.864 | 0.882 | 0.8309 | 0.8504 | 88,759 |
| 21/11/25 | 0.8466 | 0.8747 | 0.831 | 0.8542 | 54,444 |
| 20/11/25 | 0.865 | 0.905 | 0.8301 | 0.85 | 224,839 |
| 19/11/25 | 0.877 | 0.90 | 0.85 | 0.8538 | 120,012 |
| 18/11/25 | 0.8829 | 0.8829 | 0.84 | 0.86 | 59,303 |
| 17/11/25 | 0.899 | 0.95 | 0.8755 | 0.8829 | 85,849 |
| 14/11/25 | 0.89 | 0.9544 | 0.84 | 0.8992 | 171,741 |
| 13/11/25 | 0.98 | 1.0242 | 0.91 | 0.9122 | 200,464 |
|
|
||||
|
|
||||
|
|